Eledon Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.06M, a 78.1% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $8.2M, a 21.3% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.55M, a 19.7% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.15M, a 3.15% increase from 2021.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.9M, a 149% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.55M -$1.61M -19.7% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-08-19
2022 $8.15M +$249K +3.15% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-08-19
2021 $7.9M +$4.73M +149% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $3.17M +$1.86M +142% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $1.31M -$235K -15.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $1.54M +$964K +166% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-17
2017 $579K +$408K +239% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $171K -$2.73M -94.1% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $2.9M +$793K +37.6% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-03
2014 $2.11M +$1.87M +786% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 $238K +$28K +13.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 $210K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.